FDA regulations are influencing medical practice standards and abortion pill usage trends, involving the AMA and Guttmacher Institute.
2 reports, 2 independent
Updated Jun 22
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA regulations are influencing medical practice standards and abortion pill usage trends, involving the AMA and Guttmacher Institute.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Data released by the Guttmacher Institute indicates that patient flows within the abortion care market are showing a noticeable decline.Sub-event
- FDA policy changes affecting abortion pill access are occurring in Colorado, involving Hassan Abbas.Sub-event
FDA changes affect medical practice standards and abortion pill usage trends.1 source
Keep exploring
The entities involved
- FDA
-
American Medical Association
United States association of physicians and medical students
-
Guttmacher Institute
research and policy organization
Nothing else this week.
Related events
- ISO standards are influencing regulatory requirements across the industry.
- The FDA is currently reviewing concerns regarding mail-order abortion pills and the circulation of mifepristone.
- An AI-designed drug is currently in trials, prompting a focus on global legal and ethical standards.
- Ohio covers FDA-approved uses of drugs, supported by scientific basis from the National Institutes of Health.
- AMA urges FDA to maintain standards as federal government implements marijuana rescheduling order amid GAO findings of regulatory deficiencies.